Glucose Metabolism and Live Birth Outcomes in PCOS
NCT04364087 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1208
Last updated 2025-08-24
Summary
Polycystic ovary syndrome (PCOS) is a common endocrine and reproductive disorder in which insulin resistance (IR) is proposed as a key pathophysiological feature of the disease's symptoms and consequences. Diabetes and rediabetes, a significant consequence of IR, are related to a higher risk of diabetes mellitus, future cardiovascular events, and adverse pregnancy outcomes.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Oral glucose tolerance test
Oral glucose tolerance test with 75 g glucose (75 g OGTT) will be performed to those with normal fasting glucose and HbA1C levels. Women will be recommended to have normal diet for 3 days and overnight fasting for at least 8 hours. The blood withdrawal will be performed twice: (i) fasting and (2i) 2 hours after solution administration. The volume of blood for each test is 2 ml. Impaired glucose tolerance will be diagnosed when two-hour glucose levels of 140 to 199 mg/dL (7.8 to 11.0 mmol/l) (American Diabetes Association, 2018).
Sponsors & Collaborators
-
Mỹ Đức Hospital
lead OTHER
Principal Investigators
-
Lan TN Vuong, MS, PhD · Mỹ Đức Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-01
- Primary Completion
- 2022-08-31
- Completion
- 2022-08-31
Countries
- Vietnam
Study Locations
More Related Trials
-
Efficacy of Metformin in Lean Women With Polycystic Ovary Syndrome
NCT00319293 ·Status: UNKNOWN ·Phase: NA
-
Study to Assess the Effect of Metformin Supplementation on IVF Outcome in Patients With Polycystic Ovarian Syndrome.
NCT03086005 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Metabolic Surgery on Live Birth Rate of Offspring in Obesity Polycystic Ovarian Syndrome Patients
NCT04151459 ·Status: UNKNOWN ·Phase: NA
-
CRD vs. Met in Patients With Obese PCOS Infertility
NCT06049186 ·Status: RECRUITING ·Phase: NA
-
Endometrial Effects of Metformin Action in Women With Polycystic Ovarian Syndrome (PCOS)
NCT01070160 ·Status: COMPLETED
-
Vaginal Administration of Metformin in PCOS Patients.
NCT02026869 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Comparing the Effects of Oral Contraceptive Pills Versus Metformin
NCT03229057 ·Status: COMPLETED ·Phase: PHASE3
-
Metformin and Gestational Diabetes in High-risk Patients: a RCTs
NCT00883259 ·Status: UNKNOWN ·Phase: PHASE4
-
Long Term Metformin in Women With Polycystic Ovary Syndrome
NCT04043221 ·Status: COMPLETED
-
The Effects of OCP and Metformin on Clinical, Hormonal, Metabolic and Ultrasonographic Characteristics in PCOS
NCT02866786 ·Status: COMPLETED ·Phase: PHASE4
-
Ovulation Induction in Women With Clomiphene Citrate Resistant PCOS
NCT01909141 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Insulin Sensitizers Role in Control of PCOS Vicious Cycle.
NCT06170463 ·Status: COMPLETED ·Phase: PHASE1
-
Ovulation Induction in Clomiphene Citrate Resistant PCO Women
NCT02341703 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Screening for GDM in Women With PCOS and Controls
NCT02183558 ·Status: COMPLETED ·Phase: NA
-
Metformin for Prevention Gestational Diabetes in Pregnant Women With Polycystic Ovarian Syndrome
NCT02802215 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS
NCT03236740 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Metformin Therapy on Serum Under-carboxylated Osteocalcin Levels in Hyperandrogenic Lean Polycystic Ovarian Syndrome Women
NCT02244567 ·Status: UNKNOWN ·Phase: PHASE1
-
SGLT2 Inhibitors in Patients With PCOS
NCT04700839 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Metformin and Diane-35 on PCOS Patients,a Randomized, Controlled, Prospective Clinical Trial
NCT01573377 ·Status: COMPLETED ·Phase: NA
-
OCP vs Metformin for Improvement in Clinical Symptoms and Metabolic Markers in Indian PCOS Women
NCT02744131 ·Status: UNKNOWN ·Phase: NA
-
Study of Brain Function in Women With Insulin Resistant Polycystic Ovary Syndrome
NCT00670800 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenetics of Metformin Action in PCOS
NCT00703508 ·Status: COMPLETED ·Phase: NA
-
Metformin in Patients With PCOS and Predictors of Poor Ovarian Response Ongoing In-vitro Fertilization
NCT01208740 ·Status: TERMINATED ·Phase: PHASE4
-
LOD vs Gn in Anovulatory PCOs Resistant to First Line Agents
NCT04325295 ·Status: UNKNOWN ·Phase: NA
-
Metformin Treatment in Polycystic Ovary Syndrome (PCOS)
NCT02198417 ·Status: UNKNOWN ·Phase: NA